Trial intelligence / Profile preview

Atelocollagen/minocycline plug to prevent MRONJ after tooth extraction in patients on high-dose antiresorptive therapy

jRCTs071200006Completed

Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of minocycline in medication-related osteonecrosis of the jaw (MRONJ) (2 arms). Primary endpoint: Incidence of MRONJ at 2 months after tooth extraction. Started Jul 2020; status: completed.

02

Drugs

minocycline
03

Conditions

medication-related osteonecrosis of the jaw (MRONJ)

Beyond the preview

Go deeper on jRCTs071200006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071200006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call